JP2018528182A5 - - Google Patents

Download PDF

Info

Publication number
JP2018528182A5
JP2018528182A5 JP2018505739A JP2018505739A JP2018528182A5 JP 2018528182 A5 JP2018528182 A5 JP 2018528182A5 JP 2018505739 A JP2018505739 A JP 2018505739A JP 2018505739 A JP2018505739 A JP 2018505739A JP 2018528182 A5 JP2018528182 A5 JP 2018528182A5
Authority
JP
Japan
Prior art keywords
compound
formula
reacting
configuration
reacted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018505739A
Other languages
English (en)
Japanese (ja)
Other versions
JP6816106B2 (ja
JP2018528182A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/045553 external-priority patent/WO2017024134A1/en
Publication of JP2018528182A publication Critical patent/JP2018528182A/ja
Publication of JP2018528182A5 publication Critical patent/JP2018528182A5/ja
Application granted granted Critical
Publication of JP6816106B2 publication Critical patent/JP6816106B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018505739A 2015-08-05 2016-08-04 6−ピリジル−1,3,5−トリアジン−2,4−ジオール及び6−ピリジル−1,3,5−トリアジン−2,4−ジアミンを調製する方法 Active JP6816106B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562201546P 2015-08-05 2015-08-05
US62/201,546 2015-08-05
PCT/US2016/045553 WO2017024134A1 (en) 2015-08-05 2016-08-04 Methods of preparing 6-(aryl or heteroaryl)-1,3,5-triazine-2,4-diols and 6-(aryl or heteroaryl)-1,3,5-triazine-2,4-diamines

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020213670A Division JP2021063097A (ja) 2015-08-05 2020-12-23 6−(アリールまたはヘテロアリール)−1,3,5−トリアジン−2,4−ジオール及び6−(アリールまたはヘテロアリール)−1,3,5−トリアジン−2,4−ジアミンを調製する方法

Publications (3)

Publication Number Publication Date
JP2018528182A JP2018528182A (ja) 2018-09-27
JP2018528182A5 true JP2018528182A5 (cg-RX-API-DMAC7.html) 2019-09-19
JP6816106B2 JP6816106B2 (ja) 2021-01-20

Family

ID=56684781

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018505739A Active JP6816106B2 (ja) 2015-08-05 2016-08-04 6−ピリジル−1,3,5−トリアジン−2,4−ジオール及び6−ピリジル−1,3,5−トリアジン−2,4−ジアミンを調製する方法
JP2020213670A Pending JP2021063097A (ja) 2015-08-05 2020-12-23 6−(アリールまたはヘテロアリール)−1,3,5−トリアジン−2,4−ジオール及び6−(アリールまたはヘテロアリール)−1,3,5−トリアジン−2,4−ジアミンを調製する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020213670A Pending JP2021063097A (ja) 2015-08-05 2020-12-23 6−(アリールまたはヘテロアリール)−1,3,5−トリアジン−2,4−ジオール及び6−(アリールまたはヘテロアリール)−1,3,5−トリアジン−2,4−ジアミンを調製する方法

Country Status (8)

Country Link
US (1) US9751863B2 (cg-RX-API-DMAC7.html)
EP (1) EP3331866B1 (cg-RX-API-DMAC7.html)
JP (2) JP6816106B2 (cg-RX-API-DMAC7.html)
CN (1) CN108349933A (cg-RX-API-DMAC7.html)
AU (2) AU2016303614A1 (cg-RX-API-DMAC7.html)
CA (1) CA2993615A1 (cg-RX-API-DMAC7.html)
MX (1) MX365590B (cg-RX-API-DMAC7.html)
WO (1) WO2017024134A1 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017529382A (ja) 2014-09-29 2017-10-05 アギオス ファーマシューティカルス,インコーポレーテッド 治療活性を有する化合物及びその使用方法
JP7220986B6 (ja) 2015-02-04 2024-02-08 アジオス ファーマシューティカルズ, インコーポレイテッド 治療効果のある化合物及びその使用方法
US9751863B2 (en) * 2015-08-05 2017-09-05 Agios Pharmaceuticals, Inc. Therapeutically active compounds and their methods of use
KR20180063125A (ko) 2015-10-15 2018-06-11 아지오스 파마슈티컬스 아이엔씨. 악성종양을 치료하기 위한 복합 요법
US10695352B2 (en) 2015-10-15 2020-06-30 Celgene Corporation Combination therapy for treating malignancies
ES2905915T3 (es) 2015-12-04 2022-04-12 Servier Lab Procedimientos de tratamiento de neoplasias malignas
MA43640A (fr) 2016-02-26 2018-11-28 Agios Pharmaceuticals Inc Inhibiteurs de idh1 pour le traitement de cancers hématologiques et de tumeurs solides
MX392941B (es) 2016-09-07 2025-03-24 Celgene Corp Composiciones para comprimidos.
WO2018204787A1 (en) 2017-05-05 2018-11-08 Memorial Sloan Kettering Cancer Center Methods of treatment of myeloproliferative neoplasm
US20220017490A1 (en) 2018-11-02 2022-01-20 Celgene Corporation Co-crystals of 2-methyl-1 -[(4-[6-(trifluoromethyl)pyridin-2-yl]-6-{[2-(trifluoromethyl) pyridin-4-yl]amino}-1,3,5-triazin-2-yl)amino]propan-2-ol, compositions and methods of use thereof
WO2020092894A1 (en) 2018-11-02 2020-05-07 Celgene Corporation Solid forms of 2-methyl-1-[(4-[6-(trifluoromethyl) pyridin-2-yl]-6-{[2-(trifluoromethyl)pyridin-4-yl]amino}-1,3,5-triazin-2-yl) amino]propan-2-ol
US20220017489A1 (en) 2018-11-02 2022-01-20 Celgene Corporation Solid dispersions for treatment of cancer
JP2023503842A (ja) 2019-11-14 2023-02-01 セルジーン コーポレーション がんを処置するための小児用製剤
CN111592524B (zh) * 2020-05-20 2023-11-17 温州市天聚万迅信息科技有限公司 恩西德尼的制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2390529A (en) 1942-02-03 1945-12-11 Ernst A H Friedheim Hydrazino-1,3,5-triazino derivatives of substituted phenylarsenic compounds
JPS5170779A (ja) * 1974-12-17 1976-06-18 Nippon Shinyaku Co Ltd Shinkinaguanamidoruino seiho
JPS58186682A (ja) 1982-04-27 1983-10-31 日本化薬株式会社 セルロ−ス又はセルロ−ス含有繊維材料の染色法
DE3512630A1 (de) 1985-04-06 1986-10-23 Hoechst Ag, 6230 Frankfurt Verfahren zum faerben oder bedrucken von cellulosefasern oder cellulosemischfasern
DE59106971D1 (de) 1990-07-12 1996-01-11 Ciba Geigy Ag Verfahren zur photochemischen und thermischen Stabilisierung von Polyamid-Fasermaterialien.
JPH11158073A (ja) 1997-09-26 1999-06-15 Takeda Chem Ind Ltd アデノシンa3拮抗剤
AU5379900A (en) 1999-06-07 2000-12-28 Shire Biochem Inc. Thiophene integrin inhibitors
EP2256108B1 (en) 2002-07-18 2016-03-23 Janssen Pharmaceutica NV Substituted triazine kinase inhibitors
JP5450381B2 (ja) 2007-04-30 2014-03-26 プロメティック・バイオサイエンスィズ・インコーポレーテッド 化合物、そのような化合物を含有する組成物、及びそのような化合物を用いるがん及び自己免疫疾患の治療法
GB0805477D0 (en) 2008-03-26 2008-04-30 Univ Nottingham Pyrimidines triazines and their use as pharmaceutical agents
WO2010144338A1 (en) 2009-06-08 2010-12-16 Abraxis Bioscience, Llc Triazine derivatives and their therapeutical applications
PE20142098A1 (es) * 2012-01-06 2015-01-08 Agios Pharmaceuticals Inc Compuestos terapeuticamente activos y sus metodos de uso
KR20140131955A (ko) 2012-03-09 2014-11-14 카나 바이오사이언스 인코포레이션 신규 트리아진 유도체
WO2015003360A2 (en) * 2013-07-11 2015-01-15 Agios Pharmaceuticals, Inc. Therapeutically active compounds and their methods of use
AU2014287122B9 (en) 2013-07-11 2018-11-01 Les Laboratoires Servier N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as IDH2 mutants inhibitors for the treatment of cancer
AU2014295938B2 (en) 2013-08-02 2018-07-19 Les Laboratoires Servier Therapeutically active compounds and their methods of use
JP2017529382A (ja) 2014-09-29 2017-10-05 アギオス ファーマシューティカルス,インコーポレーテッド 治療活性を有する化合物及びその使用方法
JP7220986B6 (ja) 2015-02-04 2024-02-08 アジオス ファーマシューティカルズ, インコーポレイテッド 治療効果のある化合物及びその使用方法
US9751863B2 (en) * 2015-08-05 2017-09-05 Agios Pharmaceuticals, Inc. Therapeutically active compounds and their methods of use

Similar Documents

Publication Publication Date Title
JP2018528182A5 (cg-RX-API-DMAC7.html)
JP2021063097A5 (cg-RX-API-DMAC7.html)
JP2009527517A5 (cg-RX-API-DMAC7.html)
DK2958903T3 (en) METHOD OF PREPARING VORTIOXETIN
JP2010505926A5 (cg-RX-API-DMAC7.html)
JP2009533369A5 (cg-RX-API-DMAC7.html)
RU2012138259A (ru) Способ получения ривароксабана
JP2013525264A5 (cg-RX-API-DMAC7.html)
JP2013525265A5 (cg-RX-API-DMAC7.html)
JP2016121177A5 (cg-RX-API-DMAC7.html)
JP2014518240A5 (cg-RX-API-DMAC7.html)
Chen et al. Meglumine: an efficient, biodegradable, and recyclable green catalyst for one-pot synthesis of functionalized dihydropyridines
Talukdar et al. Ullmann-Type N-, S-, and O-Arylation Using a Well-Defined 7-Azaindole-N-oxide (7-AINO)-Based Copper (II) Catalyst: Scope and Application to Drug Synthesis
JP2016503812A5 (cg-RX-API-DMAC7.html)
Wu et al. Dual role of BrCF 2 CO 2 Et: difluorocarbene-enabled access to α-trifluoromethyl ketones from sulfoxonium ylides
ES2587942T3 (es) Compuestos de fenilimidazol
Carril et al. Recyclable copper-catalyst in aqueous media: O-and N-arylation reactions towards the benzofuroindole framework
JP2018505179A5 (cg-RX-API-DMAC7.html)
NO20081859L (no) Fremgangsmate for fremstillingen av sartanderivater og mellomprodukter som er nyttige i slike fremgangsmater
CN111757870A (zh) 合成甲磺草胺的方法
JP2762430B2 (ja) アラルキルアミノピリミジン類の製法
ATE498617T1 (de) Verfahren zur herstellung einer 3-o- alkylascorbinsäure
CN104540818A (zh) 环烷醇衍生物制备方法及唑衍生物制备方法
JP3161690B2 (ja) 2−メルカプトイミダゾール縮合環化合物の製造法
CA2584789A1 (en) Method for the preparation of aripiprazole, and corresponding intermediates and their preparation